Background
==========

In hemodialysis patients, the choice of vascular access type is of primary importance. It is generally accepted that long-term use of catheters can cause vein stenosis \[[@B1],[@B2]\], and catheters are associated with adverse outcomes such as infections and complications \[[@B3]\], compared with arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs). Additionally, rates of morbidity and mortality are lower for patients who use an internal access (AVF or AVG) \[[@B4]-[@B15]\], use of intravenous iron and/or erythropoietin is often lower \[[@B16]-[@B18]\], and health care-related costs may be lower \[[@B19]-[@B22]\]. Clinical guidelines established by the National Kidney Foundation cite these reasons in advocating use of AVFs whenever possible \[[@B23]\]. The Fistula First campaign was developed to promote use of AVFs for dialysis patients \[[@B24],[@B25]\]. Placement rates for each type of access have changed dramatically over the last 10 years \[[@B26]\], with a decrease in catheter placement rates and an increase in AVF placement rates.

In 2005, the Centers for Medicare & Medicaid Services (CMS) revised the end-stage renal disease (ESRD) Medical Evidence Report (form CMS-2728) to collect information regarding the type of access used at the first outpatient dialysis session for incident patients. While some studies have used the vascular access data from form CMS-2728, lack of validation of those data is cited as a limitation by several authors \[[@B27]-[@B30]\]. Previous studies have attempted to validate other data from form CMS-2728, resulting in varying levels of validity and reliability \[[@B31]-[@B33]\].

Beginning in July 2010, outpatient dialysis facilities were required to report the type of vascular access used for dialysis on claims submitted to Medicare for payment. This represented the first time that vascular access was reported on Medicare claims, and provided an opportunity to compare the reported access on form CMS-2728 with the reported access on Medicare claims. The purpose of this study was to determine the agreement between the reported vascular access at initiation from these two data sources.

Methods
=======

Patients
--------

To ensure the presence of Medicare outpatient dialysis claims at hemodialysis initiation, only patients who were eligible for Medicare before ESRD onset were considered (for patients not Medicare eligible at initiation, Medicare eligibility does not begin until the fourth month of dialysis). Using the United States Renal Data System (USRDS) database, we identified patients aged 67 years or older at the time of initiation who began hemodialysis as their first mode of renal replacement therapy in July through December 2010, and who were Medicare eligible with Medicare as their primary payer. Patients with missing or invalid data from form CMS-2728 were excluded. Eligible patients were also required to have at least one valid Medicare outpatient dialysis claim within 14 days after their ESRD incidence date. Patient characteristics were obtained from the USRDS enrollment database.

Vascular access
---------------

The type of vascular access reported on form CMS-2728 was obtained from question 18d, "What access was used on first outpatient dialysis?" Dialysis claims were identified through the use of revenue center codes (0820 through 0829). To determine the vascular access reported on the first Medicare outpatient dialysis claim after hemodialysis initiation, Healthcare Common Procedure Coding System (HCPCS) modifier codes were used; the modifiers V5, V6, and V7 indicate catheter, AVG, and AVF, respectively.

Analysis
--------

For each patient, the reported access from each data source was compiled, and the percent agreement represented the percent of patients for whom the access was the same (i.e., catheter, AVF, or AVG). The Kappa statistic was calculated as another measure of agreement \[[@B34],[@B35]\]. Multivariate logistic analysis was performed to identify characteristics associated with the agreement of reported access. The dichotomous response variable was whether or not the reported access from the two data sources agreed (1) or disagreed (0).

Studies conducted under the auspices of the USRDS are exempt from institutional review board approval.

Results
=======

Of the 13,662 incident hemodialysis patients aged 67 years or older with Medicare coverage at initiation, 211 had an invalid form CMS-2728 or unknown vascular access, and another 3674 lacked an outpatient dialysis claim within 14 days of initiation, resulting in a final study cohort of 9777 patients. The average age was 77.2 years with a range of 67 to 102 years (Table  [1](#T1){ref-type="table"}). About three-fourths of patients were white, and another 18% were African American. About 8% of patients identified as Hispanic. The most common primary causes of renal failure were diabetes (40%) and hypertension (39%).

###### 

**Patient characteristics (*n*= 9777)**

        **Variable**         ***n*or mean (SD)**   **Percent**
  ------------------------- --------------------- -------------
         Age, years                                      
             Mean                77.2 (6.6)              
            67-74                   3770              38.6
            75-84                   4478              45.8
             ≥ 85                   1529              15.6
             Sex                                         
             Male                   5213              53.3
            Female                  4563              46.7
            Race                                         
            White                   7457              76.3
       African American             1784              18.2
    Asian/Pacific Islander           442               4.5
            Other                    94                1.0
          Ethnicity                                      
           Hispanic                  760               7.8
         Non-Hispanic               9017              92.2
    Primary cause of ESRD                                
           Diabetes                 3910              40.0
         Hypertension               3772              38.6
        Other/unknown               2095              21.4

*ESRD*, End-stage renal disease; *SD*, Standard deviation.

The distribution of vascular access type identified by each data source and the number of instances of agreement and disagreement appear in Table  [2](#T2){ref-type="table"}. One patient for whom modifier codes indicated both a catheter and an AVG on the first outpatient dialysis claim was included in the catheter category. The two data sources produced very similar distributions of vascular access use (78% catheter, 18% AVF, 4% AVG), and the two sources agreed on the reported access type for 94% of patients, with a Kappa statistic of 0.83 (*P* = 0.0066, 95% confidence interval 0.82-0.85).

###### 

Agreement of reported access

                                                 **Access reported on first outpatient dialysis claim**                              
  ---------------------------------- ---------- -------------------------------------------------------- ------------- ------------- -------------
   Access reported on form CMS-2728   Catheter                            7406                                189           63        7658 (78.3)
                 AVF                    200                               1490                                58        1748 (17.9)  
                 AVG                     34                                29                                 308        371 (3.8)   
                                       Total                          7640 (78.1)                         1708 (17.5)    429 (4.4)       9777

*Note:* Values are *n* or *n* (%).

*AVF*, Arteriovenous fistula; *AVG*, Arteriovenous graft; *CMS*, Centers for Medicare & Medicaid Services.

Results of the multivariate logistic regression (Table  [3](#T3){ref-type="table"}) suggest that agreement was not associated with the patient characteristics of age, sex, race, Hispanic ethnicity, or primary cause of renal failure. In fact, the *P* value for the global test for the model was non-significant (likelihood ratio *P* = 0.15), indicating no evidence that any included variable was associated with the agreement in reported vascular access.

###### 

Multivariate logistic regression on the agreement of vascular access

        **Variable**        **Estimated odds ratio**   ***P***
  ------------------------ -------------------------- ---------
          Male sex                 Reference               
         Female sex                   0.97             0.7296
      Age 67--74 years             Reference               
      Age 75--84 years                0.92             0.3720
       Age ≥ 85 years                 1.09             0.5321
         White race                Reference               
   African American race              0.81             0.0520
         Other race                   0.80             0.2183
   Non-Hispanic ethnicity          Reference               
     Hispanic ethnicity               1.26             0.2067

Discussion
==========

This study represents the first time that vascular access data from form CMS-2728 have been compared with the access type reported on Medicare outpatient claims for the same patients. In general, we found excellent agreement between the two data sources; 94% of the time, the reported access was the same, and the Kappa value of 0.83 is above the threshold of 0.75 typically associated with an indication of excellent agreement \[[@B36]\]. Additionally, from multivariate logistic regression, instances of disagreement appeared to be independent of the patient characteristics of age, sex, race, and primary cause of renal failure. This is encouraging, because it suggests that the validity is likely to be equally strong across different patient populations. Disagreement was more common when an AVF or AVG was reported than when a catheter was reported. However, the use and reporting of catheters far out-number the use and reporting of AVFs or of AVGs, and the distribution of access type reported is in line with the overall distribution. For example, for the 258 cases in which outpatient claims did not agree with AVF access reported on form CMS-2728, 78% of the time the outpatient claims indicated catheter use, which is exactly the percentage of catheters reported overall, and what would be expected if disagreement were random.

The limitations of this study should be noted. The study population was limited to patients aged 67 years or older, and the distribution of the access type used (and reported) may not be representative of the entire incident hemodialysis population. However, the analysis of this population suggested that the validity was not associated with age, and while the results are not generalizable to the population aged younger than 67 years, there is nothing to indicate that validity would differ significantly in a younger population. Another limitation is that form CMS-2728 may be filled out weeks or months after dialysis initiation, with unknown consequences for the reliability of the information on the form. However, for patients in this study, the date of the physician's signature on the form occurred, on average, 20.4 days after the date that regular dialysis began, and did not differ significantly (*P* = 0.36) for patients with access type agreement (20.5 days) vs. those with lack of agreement (19.6 days) on the first outpatient dialysis Medicare claim. Also, dialysis providers are required to report only the vascular access used for the last hemodialysis session of the month, and reporting the access at each session is at the provider's discretion. Therefore, in some cases, the access reported on the dialysis claim may not reflect the access used for the first outpatient dialysis session. (In fact, agreement when form CMS-2728 indicates a catheter is slightly worse when the form also indicates presence of a maturing AVF or AVG, possibly reflecting instances of a catheter being used at the first session and an AVF or AVG having matured by the end of the month and thus appearing on the outpatient claim). However, this situation would only serve to increase the difficulty of concordance with form CMS-2728, making our findings all the more encouraging. For researchers hoping to resolve cases in which the data sources disagree, searching for claims involving access procedures (insertions, removals, complications) may provide additional information regarding the type or types of access present at initiation. Finally, this study simply investigated concordance between two data sources, not concordance with type of vascular access actually present, which is ultimately unknown. Future study is warranted, perhaps involving primary data collection regarding the true vascular access used at each dialysis session, to compare with access reported on claims and on form CMS-2728.

Conclusions
===========

The degree of agreement between form CMS-2728 and outpatient dialysis claims reporting of the type of vascular access used at hemodialysis initiation should give researchers confidence in using data from either source in future studies.
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